The aim of the present study was to compare the general health in athlete and non-athlete women. The statistical population of the present study included all athlete and non-athlete women in Shiraz, Iran. The sample consisted of 764 subjects (382 athletes, 382 non- athletes) that the athletes sample selected by Gerjesy and Morgan sample size table and non-athletes sample selected by purposeful sampling method. The General Health Questionnaire (Goldberg, 1978) was used for measuring the general health. Independent t-test and multivariate analysis of variance (MANOVA) tests were used for data analysis. The results showed a significant difference between athlete and non-athlete women in the general health and its subscales (<0.05). According to this finding, general health in athletes is better than non-athlete women. Regarding the findings of this study, it can be argued that sport activities are effective in improving general health of women.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763711 | PMC |
http://dx.doi.org/10.4081/hpr.2019.8047 | DOI Listing |
Environ Sci Process Impacts
January 2025
Department of Otorhinolaryngology, No. 971 Hospital of People's Liberation Army Navy, Qingdao 266000, Shandong Province, China.
Hearing loss (HL) is an otolaryngology disease susceptible to environmental pollutants. Volatile organic compounds (VOCs), as a class of chemical pollutants with evaporation propensity, pose a great threat to human health. However, the association between VOCs and HL remains unclear.
View Article and Find Full Text PDFBr J Clin Pharmacol
January 2025
F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Aims: Crovalimab is a novel C5 inhibitor administered first intravenously and then subcutaneously in patients with paroxysmal nocturnal haemoglobinuria (PNH) naive to complement inhibition or switching from eculizumab or ravulizumab. Crovalimab showed efficacy and safety comparable to eculizumab in the pivotal COMMODORE 2 and supporting studies.
Methods: We characterized crovalimab pharmacokinetics and the relationship between exposure pharmacokinetic parameters and pharmacodynamic biomarkers, efficacy and safety endpoints using pooled data (healthy volunteers [n = 9], naive [n = 210] and switched [n = 211] patients).
Spine (Phila Pa 1976)
January 2025
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
Study Design: Systematic Review and Meta-analysis.
Objective: This study aims to compare the efficacy and safety of surgical and endovascular treatments for SDAVFs.
Summary Of Background Data: Spinal dural arteriovenous fistulas (SDAVFs) result from an abnormal connection between the radiculomeningeal artery and the radicular vein, leading to venous hypertension and potential neurological damage.
Pediatr Obes
January 2025
Growth, Exercise, Nutrition and Development (GENUD) Research Group, Instituto Agroalimentario de Aragón (IA2), University of Zaragoza, Zaragoza, Spain.
Background: Although the genetic interplay with the environment has a major impact on obesity development, little is known on whether breastfeeding could modulate the genetic predisposition to obesity.
Objectives: To investigate whether breastfeeding attenuates the effect of an obesity genetic risk score (GRS) on adiposity in European adolescents.
Methods: Totally 751 adolescents from the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross-sectional study were included, divided according to breastfeeding status into never breastfed, 1-3 months and ≥4 months.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!